Salem Radio Network News Sunday, June 20, 2021


Delaware pharmaceutical company agrees to pay $12.6 million to resolve kickback allegations


A Delaware pharmaceutical company has agreed to pay $12.6 million to resolve allegations that it violated the federal False Claims Act by paying kickbacks

VERBATIM: Federal officials say the settlement resolves allegations that Incyte Corporation improperly used an independent foundation to cover copays of certain people taking the company’s cancer drug Jakafi from 2011 to 2014. Officials say the scheme resulted in Incyte causing false claims for Jakafi to be submitted to Medicare and to the federal health care program for military members. Incyte denies any wrongdoing and says the settlement agreement is not an admission of liability.


Editorial Cartoons

View More »

Gary Varvel
Thu, Jun 10, 2021